Microbial platform technology for recombinant antibody fragment production: a review

SK Gupta, P Shukla - Critical reviews in microbiology, 2017 - Taylor & Francis
Recombinant antibody fragments are being used for the last few years as an important
therapeutic protein to cure various critical and life threatening human diseases. Several …

Bioengineering of antibody fragments: challenges and opportunities

S Pirkalkhoran, WR Grabowska, HH Kashkoli… - Bioengineering, 2023 - mdpi.com
Antibody fragments are used in the clinic as important therapeutic proteins for treatment of
indications where better tissue penetration and less immunogenic molecules are needed …

Evolution of Escherichia coli Expression System in Producing Antibody Recombinant Fragments

A Sandomenico, JP Sivaccumar, M Ruvo - International Journal of …, 2020 - mdpi.com
Antibodies and antibody-derived molecules are continuously developed as both therapeutic
agents and key reagents for advanced diagnostic investigations. Their application in these …

Cell-free synthesis meets antibody production: a review

M Stech, S Kubick - Antibodies, 2015 - mdpi.com
Engineered antibodies are key players in therapy, diagnostics and research. In addition to
full size immunoglobulin gamma (IgG) molecules, smaller formats of recombinant …

Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs

A De Marco - Microbial cell factories, 2015 - Springer
Background Antibodies have been a pillar of basic research, while their relevance in clinical
diagnostics and therapy is constantly growing. Consequently, the production of both …

Production of recombinant antibody fragments in Bacillus megaterium

E Jordan, M Hust, A Roth, R Biedendieck… - Microbial cell …, 2007 - Springer
Background Recombinant antibodies are essential reagents for research, diagnostics and
therapy. The well established production host Escherichia coli relies on the secretion into …

Making antibodies in bacteria

FA Fellouse, SS Sidhu - Making and using antibodies, 2006 - taylorfrancis.com
Phage-Displayed Library.................................................. 169 8.3. 2.4 Preparation of
Electrocompetent E. coli SS320.............. 170 8.3. 2.5 E. coli Electroporation and Phage …

Single-chain antibody fragments: Purification methodologies

LP Malpiedi, CA Diaz, BB Nerli, A Pessoa Jr - Process Biochemistry, 2013 - Elsevier
At present, single-chain variable fragments (scFv) of antibodies are considered one of the
most important tools in human therapies. Wide applications of antibodies are being …

Microbials for the production of monoclonal antibodies and antibody fragments

O Spadiut, S Capone, F Krainer, A Glieder… - Trends in …, 2014 - cell.com
Monoclonal antibodies (mAbs) and antibody fragments represent the most important
biopharmaceutical products today. Because full length antibodies are glycosylated …

Evaluation of scFv protein recovery from E. coli by in vitro refolding and mild solubilization process

A Sarker, AS Rathore, RD Gupta - Microbial Cell Factories, 2019 - Springer
Background The production of therapeutically active single chain variable fragment (scFv)
antibody is still challenging in E. coli due to the aggregation propensity of recombinant …